0001127602-23-021020.txt : 20230719
0001127602-23-021020.hdr.sgml : 20230719
20230719165318
ACCESSION NUMBER: 0001127602-23-021020
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20230630
FILED AS OF DATE: 20230719
DATE AS OF CHANGE: 20230719
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mcconnell Jill G.
CENTRAL INDEX KEY: 0001979544
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41704
FILM NUMBER: 231097299
MAIL ADDRESS:
STREET 1: 8 MOORE DRIVE
CITY: DURHAM
STATE: NC
ZIP: 27703
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Fortrea Holdings Inc.
CENTRAL INDEX KEY: 0001965040
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 922796441
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8 MOORE DRIVE
CITY: DURHAM
STATE: NC
ZIP: 27709
BUSINESS PHONE: 877-495-0816
MAIL ADDRESS:
STREET 1: 8 MOORE DRIVE
CITY: DURHAM
STATE: NC
ZIP: 27709
FORMER COMPANY:
FORMER CONFORMED NAME: Silver Spinco Inc.
DATE OF NAME CHANGE: 20230207
4/A
1
form4a.xml
PRIMARY DOCUMENT
X0508
4/A
2023-06-30
2023-07-05
0001965040
Fortrea Holdings Inc.
FTRE
0001979544
Mcconnell Jill G.
8 MOORE DRIVE
DURHAM
NC
27709
1
Chief Financial Officer
0
Restricted Stock Unit
2023-06-30
4
A
0
1708
0
A
Common Stock
1708
1708
D
Restricted Stock Unit
2023-06-30
4
A
0
3088
0
A
Common Stock
3088
4796
D
Restricted Stock Unit
2023-06-30
4
A
0
5052
0
A
Common Stock
5052
9848
D
Restricted Stock Unit
2023-06-30
4
A
0
33013
0
A
Common Stock
33013
42861
D
Restricted Stock Unit
2023-06-30
4
A
0
20776
0
A
Common Stock
20776
63637
D
Restricted Stock Unit
2023-06-30
4
A
0
2033
0
A
Common Stock
2033
65670
D
This Form 4 is amended to reflect the adjusted amount of Restricted Stock Units ("RSUs") issued to the Reporting Person in connection with the final adjustment ratio calculated pursuant to the terms of the Employee Matters Agreement (the "EMA") by and between Laboratory Corporation of America Holdings ("Labcorp") and Fortrea Holdings Inc. ("Fortrea").
Each RSU represents the contingent right to receive one share of Fortrea Holdings Inc. Common Stock.
In connection with the spin-off ("Spin-Off") of Fortrea by Labcorp, RSUs granted by Labcorp were converted into time-vesting RSUs of Fortrea pursuant to the terms of the EMA. The RSUs will vest in full on February 2, 2024.
In connection with the Spin-Off, RSUs granted by Labcorp were converted into time-vesting RSUs of Fortrea pursuant to the terms of the EMA. The RSUs will vest in two annual installments on February 11 of each of 2024 and 2025.
This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
In connection with the Spin-Off, RSUs granted by Labcorp were converted into time-vesting RSUs of Fortrea pursuant to the terms of the EMA. The RSUs vest in three equal annual installments beginning on February 7, 2024.
In connection with the Spin-Off, RSUs granted by Labcorp were converted into time-vesting RSUs of Fortrea pursuant to the terms of the EMA. The RSUs vest in three equal annual installments beginning on June 1, 2024.
In connection with the Spin-Off, performance awards granted by Labcorp in 2021 for the three-year performance period through December 31, 2023 (the "2021 PSA") were converted into time-vesting RSUs of Fortrea pursuant to the terms of the EMA. The 2021 PSA was converted into a number of time-vesting Fortrea RSUs based on the degree of achievement of the performance criteria subject to the 2021 PSA prior to the Spin-Off and the adjustment ratio that applies to Labcorp equity awards in the Spin-Off, with vesting to occur on the 30th day following Labcorp's filing of an annual report with the SEC on Form 10-K that includes or incorporates by reference audited financial statements with respect to the 3-year period ending December 31, 2023.
In connection with the Spin-Off, performance awards granted by Labcorp in 2022 for the three-year performance period through December 31, 2024 (the "2022 PSA") were converted into time-vesting RSUs of Fortrea and performance share awards of Fortrea pursuant to the terms of the EMA. The 2022 PSA was converted into a time-vesting Fortrea RSU equal to 50% of the target number of shares subject to the 2022 PSA, after application of the adjustment ratio that applies to Labcorp equity awards in the Spin-Off, with vesting to occur on the 30th day following Labcorp's filing of an annual report with the SEC on Form 10-K that includes or incorporates by reference audited financial statements with respect to the 3-year period ending December 31, 2024, with the remainder of the 2022 PSA being converted into a performance share award of Fortrea that is not being reported on this Form.
/s/ James Stillman Hanson, Attorney-in-Fact for Jill G. McConnell
2023-07-19
EX-24
2
doc1.txt
POWER OF ATTORNEY (PUBLIC): EXHIBIT 24 - POWER OF ATTORNEY
EXHIBIT 24
POWER OF ATTORNEY
-----------------
KNOWN ALL BY THESE PRESENTS, that the undersigned hereby makes, constitutes and
appoints each of James Stillman Hanson, General Counsel of Fortrea Holdings
Inc. (the ?Company?), and Erica Smith-Klocek, Deputy General Counsel of the
Company, signing singly, with full power of substitution, the undersigned's
true and lawful attorney-in-fact to: (i) execute for and on behalf of the
undersigned, forms and authentication documents for EDGAR Filing Access; (ii)
do and perform any and all acts for and on behalf of the undersigned which may
be necessary or desirable to complete and execute any such forms and
authentication documents; (iii) execute for and on behalf of the undersigned,
in the undersigned's capacity as an officer, director and/or 10% shareholder of
the Company, Forms 3, 4 and 5 (including amendments thereto) in accordance with
Section 16(a) of the Securities Exchange Act of 1934, as amended, and the rules
thereunder; (iv) do and perform any and all acts for and on behalf of the
undersigned which may be necessary or desirable to complete and execute any
such Form 3, 4 or 5 (including amendments thereto) and timely file such form
with the United States Securities and Exchange Commission and any stock
exchange or similar authority; and (v) take any other action of any type
whatsoever in connection with the foregoing which, in the opinion of such
attorney-in-fact, may be of benefit to, in the best interests of, or legally
required by the undersigned, it being understood that the documents executed by
such attorney-in-fact on behalf of the undersigned pursuant to this Power of
Attorney shall be in such form and shall contain such terms and conditions as
such attorney-in-fact may approve in such attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might
or could do if personally present, with full power of substitution or
revocation, hereby ratifying and confirming all that such attorney-in-fact, or
such attorney-in-fact's substitute or substitutes, shall lawfully do or cause
to be done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to
comply with Section 16 of the Securities Exchange Act of 1934, as amended.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 (including amendments
thereto) with respect to the undersigned's holdings of and transactions in
securities issued by the Company, unless earlier revoked by the undersigned in
a signed writing delivered to the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed on June 7, 2023.
/s/ Jill G. Mcconnell
----------------------
Jill G. Mcconnell